DHA-pharmaceutical agent conjugates of taxanes

Details DHA-pharmaceutical agent conjugates of taxanes DHA-pharmaceutical agent conjugates of taxanes

1996-05-22

1998-08-18

Jarvis, William R. A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514549, A61K 31335, A61K 3122

Patent

active

057959099

ABSTRACT:
The invention provides conjugates of cis-docosahexaenoic acid and taxanes useful in treating cell proliferative disorders. Conjugates of paclitaxel and docetaxel are preferred.

REFERENCES:
patent: 4346085 (1982-08-01), Growdon et al.
patent: 4550109 (1985-10-01), Folkers et al.
patent: 4554272 (1985-11-01), Bock et al.
patent: 4636494 (1987-01-01), Growdon et al.
patent: 4684646 (1987-08-01), Chang et al.
patent: 4704393 (1987-11-01), Wakabayashi et al.
patent: 4814470 (1989-03-01), Colin et al.
patent: 4857653 (1989-08-01), Colin et al.
patent: 4933324 (1990-06-01), Shashoua
patent: 4939174 (1990-07-01), Shashoua
patent: 5194654 (1993-03-01), Hostetler et al.
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5250722 (1993-10-01), Bombardelli et al.
patent: 5336684 (1994-08-01), Murray et al.
patent: 5356928 (1994-10-01), Murray et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5411947 (1995-05-01), Hostetler et al.
patent: 5447936 (1995-09-01), Hausheer et al.
patent: 5453520 (1995-09-01), Bombardelli et al.
patent: 5453521 (1995-09-01), Gaullier et al.
patent: 5468754 (1995-11-01), Hausheer et al.
patent: 5473055 (1995-12-01), Mongelli et al.
patent: 5476954 (1995-12-01), Bourzat et al.
patent: 5484809 (1996-01-01), Hostetler et al.
patent: 5580899 (1996-12-01), Mayhew et a.
Stillwell et al, Chemical Abstracts, vol. 118, abstract No. 139410, 1993.
Halmos et al, Chemical Abstracts, vol. 117, abstract No. 157535, 1992.
C.S. Swindell et al., "Characterization of the Taxol Structure-Activity Profile for the Locus of the A-Ring Side Chain", Bioorganic & Medicinal Chem. Ltrs., vol. 4, No. 12, pp. 1531-1536, 1992.
J.M. Carboni et al., "Synthesis of a Photoaffinity Analog of Taxol as an Approach to Identify the Taxol Binding Site on Microtubules", Journal of Medicinal Chem. (8 Sep. 1992).
K.C. Nicolaou et al., "Design, Synthesis and Biological Activity of Protaxols", Nature, 364:464-466 (29 Jul. 1993).
G.I. Georg et al., "The Medicinal Chemistry of Taxol", in Taxol Science and Applications ed. Matthew Suffness, Boca Raton; CRC Press, Inc., 1995, pp. 317-375.
W.C. Rose, Preclinical Antitumor Activity of Taxanes, in "Taxol Science and Applications" ed. Matthew Suffness, Boca Raton; CRC Press, Inc., 1995, pp. 209-235.
T. Higuchi et al., "Prodrugs as Novel Drug Delivery Systems", American Chem. Society, ACS Symposium Series, vol. 14, pp. 14-15 (1975).
S. Iwakami et al., "Inhibition of Arachidonate 5-Lipoxygenase by Phenolic Compunds", Chem. Pharm. Bull. (Japan), 34 (9), 3960-3963, 1986.
Y. Makino et al., Chemical Abstracts, vol. 106, No. 12, issue 23 Mar. 1987, "Pharmaceuticals Permeable to Blood-Brain Barrier", p. 363, dated 10 Septemebr 1986, abstract No. 90177x.
Hesse, G.W. et al., "Uptake in brain and neurophysiological activity of two lipid esters of gamma-aminobutyric acid", Neuropharamacol. 27:637-40 (1988).
Jacob, J.N. et al., "Gama-aminobutyric acid esters, 3, Synthesis, brain uptake, and pharmacological properties of C-18 Glyceryl lipid esters of GABA with varying degree of unsaturation", Journal of Medicinal Chem. 30:1573-6 (1987).
Jacob, J.N., et al., "Synthesis, brain uptake and pharmacological propeties of a glyceryl lipid containing GABA and the GABA-T inhibitor, gamma-vinyl GABA", J. Medicinal Chem. 33:733-6 (1990).
G. Dhopeshwarker, Chemical Abstracts, vol. 76, No. 16, issued 17 Apr. 1972, "Fatty Acid Transport Into the Brain", p. 276, Abstract No. 97635c, Biochim Biophys. Acta, 255(2) 572-9.
R. Spector, Chemical Abstracts, vol. 108, No. 11, issued 14 Mar. 1988, "Fatty Acid Transport Through the Blood-Brain Barrier", p. 435, Abstract No. 92100g, J. Neurochem., 50(2), 639-43.
I. Yamatsu et al., Chemical Abstracts, vol. 100, No. 19, issued 7 May 1984, "Polyprenyl Carboxylic Acid Amides", p. 555, Abstract No. 156839z, EP91,694.
V.E. Shashoua, et al., "Gamma-Aminobutyric Acid Esters, 1, Synthesis . . . ", Journal of Medicinal Chemistry, vol. 27, No. 5, pp. 659-664 (1984).
G. Bourat et al., "Long Chain Esters of Pipotiazine as Long-Acting Psychotropic Pro-Drugs", pp. 105-114, (1976) Med. Chem. Proc. Int. Symp. 5.
K.A. Jacobson et al., "Adenosine analogs with covalently attached lipids . . . ", FEBS Letters, vol. 225, Nos. 1,2 pp. 97-102 (Dec. 1987).
A. Garzon-Aburbeh et al., "A Lymphotrophic Prodrug of L-Dopa:Synthesis", Journal of Medicinal Chemistry 29:687-691 (1986).
J.N. Jaob, et al., "Gamma-Aminobutyric Acid Esters.2.Synthesis Brain Uptake . . . ", Journal of Medicinal Chem., vol. 28, No. 1, pp. 106-110 (1985).
G.W. Hesse et al., "Inhibitory Effect of Cholesterol Gamma-Aminobutyrate", Neuropharmacology, vol. 24, No. 2, pp. 149-146 (1985).
U.K. Mazumdar & D.C. Dey, "Preparation and Evaluation of Ethambuytol Derivatives", Indian J. Pharm. Sci. 47(6):179-180 (1984).
L.M. Gunne et al., "Oral Dyskinesa in Rats Following Brain Lesios and Neuroleptic Drug Administration", Psychopharmacology 77:134-9 (1982).
R.J. Baldessarnini et al., "Dopamine and the Pathophysiology of Dyskinesis . . . ", Ann. Rev. Neurosci., 3: 23-41 (1980).
J.P. Lohr et al., "Neuroleptic-Induced Movement Disorders . . . ", Psychiatry, vol. 3, (1989).

Affiliated with

Also associated with

Rating

DHA-pharmaceutical agent conjugates of taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DHA-pharmaceutical agent conjugates of taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DHA-pharmaceutical agent conjugates of taxanes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1115103